TRHR and ocular melanoma: By contrast, for the thyrotropin-releasing hormone receptor (TRHR), androgen receptor ligand-binding domain (ARlbd), and androgen receptor with antagonist (ARant), the mean value of lnROR was significantly greater in the presence of agonist activity, indicating the potential for significantly inducing OM development (Figure 4).